TaweeTanvetyanonMD

Head & Neck Cancer, Hematologic Oncology, Thoracic Cancer

Physician

Overview of Dr. Tanvetyanon

Dr. Tawee Tanvetyanon is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from Chulalongkorn University Faculty of Medicine and has been in practice 21 years. Dr. Tanvetyanon accepts several types of health insurance, listed below. He is one of 173 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. He has more than 100 publications and over 500 citings.

Office
H Lee Moffitt Cancer Center
12902 Magnolia Drive
Tampa, FL 33613
Book by Phone+1(816) 656-3251

Education & Training

Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 2002
Chulalongkorn University Faculty of MedicineClass of 1996

Certifications & Licensure

FL State Medical License 2005 - 2025
IL State Medical License 2001 - 2005
PA State Medical License 1999 - 2001
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma.
Anne S Tsao, Ming-Hui Hsieh, Marianna Koczywas, Janet Tu, Jonathan Riess
JTO Clinical and Research Reports. 2024-12-01
Timeliness of EGFR/ALK Inhibitor Treatment and Survival in Lung Cancer: A Population-Based Analysis.
Tawee Tanvetyanon, Dung-Tsa Chen, Jhanelle E Gray
Clinical Lung Cancer. 2024-11-01
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve-Mutant Metastatic Non-Small Cell Lung...
Xiuning Le, Jyoti D Patel, Elaine Shum, Christina Baik, Rachel E Sanborn
Journal of Clinical Oncology. 2024-10-08

Press Mentions

Gene Therapy Clinical Trial for Mesothelioma Moving ForwardSeptember 23rd, 2020
COVID-19 Can Be Very Bad for Cancer Patients Who’ve Just Completed Certain Types of Treatments, Says New StudySeptember 21st, 2020
Mesothelioma Clinical Trial Combines Immunotherapy DrugsJuly 13th, 2017
Join now to see all

Insurance Accepted

Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment